Target intelligence / Profile preview

Novel transcript, antisense to INSIG2

Molecular classification
Noncoding RNA, Natural antisense transcript, Transcript
01

Overview

Novel transcript, antisense to INSIG2 (LOC107985940, ENSG00000297418) is a naturally occurring antisense transcript to the *INSIG2* gene. Natural antisense transcripts are widespread in eukaryotic genomes and are increasingly recognized as important modulators of gene expression. These transcripts can exert regulatory effects by mechanisms including RNA masking (formation of duplexes that affect splicing and stability), transcriptional interference (competition between opposing RNA polymerases), and epigenetic silencing (recruitment of chromatin-modifying complexes). While NATs are known to have tissue-specific functions and can influence gene regulation, the specific regulatory role or biological significance of LOC107985940 is currently unknown. There are no direct links to therapeutic targeting, disease associations, or known pharmacological modulators. The molecular classification is simply noncoding RNA (specifically a NAT); there is no evidence LOC107985940 encodes a protein, nor does it function as a conventional receptor, enzyme, or other protein target class. No drugs, mechanisms of action, disease associations, or safety concerns are documented for this transcript. Its primary recognized role, if any, would be regulatory—influencing *INSIG2* expression through NAT-mediated mechanisms. If further analysis or structured annotation is required, most fields should be marked as null or as not applicable except for those concerning its molecular type and general antisense transcript functions.

Other names
LOC107985940ENSG00000297418Novel transcript, antisense to INSIG2
02

Biological functions

Regulation of gene expressionPossible involvement in transcriptional interference, RNA masking, chromatin remodeling

Beyond the preview

Go deeper on Novel transcript, antisense to INSIG2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to INSIG2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call